HQH
Overvalued by 0% based on the discounted cash flow analysis.
Market cap | $891.59 Million |
---|---|
Enterprise Value | $891.59 Million |
Dividend Yield | $2.04 (11.0629067245119%) |
Earnings per Share | $1.14 |
Beta | 0.74 |
Outstanding Shares | 50,624,886 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 15.7 |
---|---|
PEG | -3.76 |
Price to Sales | 15.47 |
Price to Book Ratio | 0.77 |
Enterprise Value to Revenue | 11.03 |
Enterprise Value to EBIT | 12.36 |
Enterprise Value to Net Income | 3 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Tekla Healthcare Investors is a closed-end fund that invests in companies in the healthcare industry.